In vivo measurement of apolipoprotein e from the brain interstitial fluid using microdialysis

Molecular Neurodegeneration

Volumn 8, Issue 1, 2013, Pages

  Ulrich, Jason D ^a,b   Burchett, Jack M ^a,b   Restivo, Jessica L ^a,b   Schuler, Dorothy R ^a,b   Verghese, Philip B ^a,b   Mahan, Thomas E ^a,b   Landreth, Gary E ^d   Castellano, Joseph M ^a,b   Jiang, Hong ^a,b   Cirrito, John R ^a,b   Holtzman, David M ^a,b,c  

^a Department of Neurology ^*  (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Developmental Biology   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; Microdialysis

Indexed keywords

APOLIPOPROTEIN E;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; GEL ELECTROPHORESIS; HIPPOCAMPUS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTERSTITIAL FLUID; MICRODIALYSIS; MOUSE; NONHUMAN; WILD TYPE;

ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEINS E; BLOTTING, WESTERN; BRAIN; BRAIN CHEMISTRY; CEREBROSPINAL FLUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR FLUID; GENE KNOCK-IN TECHNIQUES; HUMANS; MICE; MICE, INBRED C57BL; MICRODIALYSIS; PROTEIN ISOFORMS;

MUS;

EID: 84876297937     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-8-13     Document Type: Article

References (27)

1. Formation and function of apolipoprotein E-containing lipoproteins in the nervous system. Vance JE, Hayashi H, Biochimica Biophysica Acta (BBA) Molecular Cell Biol Lipids 2010 1801 806 818 10.1016/j.bbalip.2010.02.007
2. Apolipoprotein e and apolipoprotein e receptors: normal biology and roles in Alzheimer disease. Holtzman DM, Herz J, Bu G, Cold Spring Harb Perspect Med 2012 2 006312 22393530
3. Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance. Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, Patterson BW, Fagan AM, Morris JC, Mawuenyega KG, Cruchaga C, Sci Transl Med 2011 3 89ra57 10.1126/scitranslmed.3002156 21715678
4. Apolipoprotein E, Especially Apolipoprotein E4, Increases the Oligomerization of Amyloid β Peptide. Hashimoto T, Serrano-Pozo A, Hori Y, Adams KW, Takeda S, Banerji AO, Mitani A, Joyner D, Thyssen DH, Bacskai BJ, J Neurosci 2012 32 15181 15192 10.1523/JNEUROSCI.1542-12.2012 23100439
5. Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. Wahrle SE, Jiang H, Parsadanian M, Kim J, Li A, Knoten A, Jain S, Hirsch-Reinshagen V, Wellington CL, Bales KR, J Clin Invest 2008 118 671 682 18202749
6. Deficiency of ABCA1 Impairs Apolipoprotein E Metabolism in Brain. Hirsch-Reinshagen V, Zhou S, Burgess BL, Bernier L, McIsaac SA, Chan JY, Tansley GH, Cohn JS, Hayden MR, Wellington CL, J Biol Chem 2004 279 41197 41207 10.1074/jbc.M407962200 15269218
7. Haploinsufficiency of Human APOE Reduces Amyloid Deposition in a Mouse Model of Amyloid-β Amyloidosis. Kim J, Jiang H, Park S, Eltorai AEM, Stewart FR, Yoon H, Basak JM, Finn MB, Holtzman DM, J Neurosci 2011 31 18007 18012 10.1523/JNEUROSCI.3773-11.2011 22159114
8. ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models. Cramer PE, Cirrito JR, Wesson DW, Lee CYD, Karlo JC, Zinn AE, Casali BT, Restivo JL, Goebel WD, James MJ, Science 2012 335 1503 1506 10.1126/science.1217697 22323736
9. Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosis. Kim J, Eltorai AEM, Jiang H, Liao F, Verghese PB, Kim J, Stewart FR, Basak JM, Holtzman DM, J Exp Med 2012 209 2149 2156 10.1084/jem.20121274 23129750
10. Overview of Brain Microdialysis. Chefer VI, Thompson AC, Zapata A, Shippenberg TS, Curr Protoc Neurosci 2009 47 7.1.1 7.1.28
11. Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo. Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, Schoepp DD, Paul SM, Mennerick S, Holtzman DM, Neuron 2005 48 913 922 10.1016/j.neuron. 2005.10.028 16364896
12. Neuronal activity regulates the regional vulnerability to amyloid-[beta] deposition. Bero AW, Yan P, Roh JH, Cirrito JR, Stewart FR, Raichle ME, Lee J-M, Holtzman DM, Nat Neurosci 2011 14 750 756 10.1038/nn.2801 21532579
13. Disruption of the Sleep-Wake Cycle and Diurnal Fluctuation of β-Amyloid in Mice with Alzheimer's Disease Pathology. Roh JH, Huang Y, Bero AW, Kasten T, Stewart FR, Bateman RJ, Holtzman DM, Sci Transl Med 2012 4 150ra122 10.1126/scitranslmed.3004291 22956200
14. In Vivo Assessment of Brain Interstitial Fluid with Microdialysis Reveals Plaque-Associated Changes in Amyloid-β Metabolism and Half-Life. Cirrito JR, May PC, O'Dell MA, Taylor JW, Parsadanian M, Cramer JW, Audia JE, Nissen JS, Bales KR, Paul SM, J Neurosci 2003 23 8844 8853 14523085
15. Novel microdialysis method to assess neuropeptides and large molecules in free-moving mouse. Takeda S, Sato N, Ikimura K, Nishino H, Rakugi H, Morishita R, Neuroscience 2011 186 110 119 21530615
16. Opposing Synaptic Regulation of Amyloid-β Metabolism by NMDA Receptors In Vivo. Verges DK, Restivo JL, Goebel WD, Holtzman DM, Cirrito JR, J Neurosci 2011 31 11328 11337 10.1523/JNEUROSCI.0607-11.2011 21813692
17. Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease. Mandrekar-Colucci S, Karlo JC, Landreth GE, J Neurosci 2012 32 10117 10128 10.1523/JNEUROSCI.5268-11.2012 22836247
18. An ABCA1-independent pathway for recycling a poorly lipidated 8.1 nm apolipoprotein E particle from glia. Fan J, Stukas S, Wong C, Chan J, May S, DeValle N, Hirsch-Reinshagen V, Wilkinson A, Oda MN, Wellington CL, J Lipid Res 2011 52 1605 1616 10.1194/jlr.M014365 21705806
19. Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice. DeMattos RB, Brendza RP, Heuser JE, Kierson M, Cirrito JR, Fryer J, Sullivan PM, Fagan AM, Han X, Holtzman DM, Neurochem Int 2001 39 415 425 10.1016/S0197-0186(01)00049-3 11578777
20. Deletion of Abca1 Increases Aβ Deposition in the PDAPP Transgenic Mouse Model of Alzheimer Disease. Wahrle SE, Jiang H, Parsadanian M, Hartman RE, Bales KR, Paul SM, Holtzman DM, J Biol Chem 2005 280 43236 43242 10.1074/jbc.M508780200 16207708
21. Unique Lipoproteins Secreted by Primary Astrocytes From Wild Type, apoE (-/-), and Human apoE Transgenic Mice. Fagan AM, Holtzman DM, Munson G, Mathur T, Schneider D, Chang LK, Getz GS, Reardon CA, Lukens J, Shah JA, LaDu MJ, J Biol Chem 1999 274 30001 30007 10.1074/jbc.274.42.30001 10514484
22. Human APOE Isoform-Dependent Effects on Brain β-Amyloid Levels in PDAPP Transgenic Mice. Bales KR, Liu F, Wu S, Lin S, Koger D, DeLong C, Hansen JC, Sullivan PM, Paul SM, J Neurosci 2009 29 6771 6779 10.1523/JNEUROSCI.0887- 09.2009 19474305
23. Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels. Riddell DR, Zhou H, Atchison K, Warwick HK, Atkinson PJ, Jefferson J, Xu L, Aschmies S, Kirksey Y, Hu Y, J Neurosci 2008 28 11445 11453 10.1523/JNEUROSCI. 1972-08.2008 18987181
24. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Liu CC, Kanekiyo T, Xu H, Bu G, Nat Rev Neurol 2013 9 106 118 10.1038/nrneurol. 2012.263 23296339
25. Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches. Rosenbaum AI, Maxfield FR, J Neurochem 2011 116 789 795 10.1111/j.1471-4159.2010.06976.x 20807315
26. Marked regional differences of brain human apolipoprotein e expression in targeted replacement mice. Sullivan PM, Mace BE, Maeda N, Schmechel DE, Neuroscience 2004 124 725 733 10.1016/j.neuroscience.2003.10.011 15026113
27. Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype. Fagan AM, Younkin LH, Morris JC, Fryer JD, Cole TG, Younkin SG, Holtzman DM, Ann Neurol 2000 48 201 210 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X 10939571